Clin2
NCT07483125Possibly a fitRecruiting

Blood pressure drop during Valsalva in hypertrophic cardiomyopathy

HCMoHCMnHCM

Part of Heart & circulation clinical trials.

This study looks at how blood pressure changes during a simple breathing exercise (the Valsalva maneuver) in people with hypertrophic cardiomyopathy, a condition where the heart muscle is thickened. It aims to understand if this test can help detect a specific type of blockage in the heart's main pumping chamber.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
800 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with hypertrophic cardiomyopathy, with or without a known blockage in the heart's outflow tract.
  • You are able to understand and sign the consent form yourself.
  • You can cooperate with simple tests like holding your breath and wearing a blood pressure monitor.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06683872Enrolling by invitation
CT heart modeling for hypertrophic obstructive cardiomyopathy

This trial uses a special CT scan to create a 3D model of your heart's blood flow. It aims to see if this model can help doctors better predict how well treatments work for people with a thick heart muscle that blocks blood flow.

Hangzhou, Zhejiang
NCT06775665Not yet recruiting
Real-world study on hypertrophic cardiomyopathy in China

This study looks at how hypertrophic cardiomyopathy (HCM) affects people in China in real-world settings. It may help doctors understand the condition better and improve care for patients like you.

Hangzhou, Zhejiang
NCT07103655Not yet recruiting· Phase 4
Mavacamten for mid-to-apical obstruction in HCM

This trial tests if mavacamten can help people with hypertrophic cardiomyopathy (HCM) who have obstruction in the middle or tip of the heart (not the usual outflow tract). You may join if you have symptoms like chest pain or shortness of breath and a pressure gradient above 30 mmHg in these areas.

Hangzhou, Zhejiang
NCT07150299Recruiting
How heart medications affect blood flow in hypertrophic cardiomyopathy

This study looks at how heart medications affect blood flow in people with obstructive hypertrophic cardiomyopathy. You will have a heart MRI before and after starting or adjusting treatment to see how your heart responds.

Vienna
NCT07638033Not yet recruiting
Real-world study of heart muscle thickening disease

This study follows patients with HCM (a condition where the heart muscle becomes abnormally thick) to understand how the disease affects them over time in everyday life. The goal is to learn more about treatment outcomes and quality of life for people living with this condition.

Xi'an, China/Shaan XI Province
NCT05818605Recruiting
Exercise training for people with hypertrophic heart muscle

This study tests whether a 24-week exercise program can improve exercise tolerance in people with hypertrophic cardiomyopathy (a thickened heart muscle). You may be asked to use phone-based tools and complete surveys during training.

San Francisco, California

Hear when a new HCM trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.